Literature DB >> 4075944

Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM.

H Beck-Nielsen, B Richelsen, C E Mogensen, T Olsen, N Ehlers, C B Nielsen, P Charles.   

Abstract

The effect of strict metabolic control for 1 yr on renal function and retinal morphology was estimated in 24 insulin-dependent diabetic individuals (age 29 +/- 8 yr, diabetes duration 10 +/- 6 yr) with Albustix negative urine and minimal or no background retinopathy before the study. They were randomized to conventional insulin treatment (CIT) or continuous subcutaneous insulin infusion (CSII) with a portable pump. During CSII treatment the metabolic status was significantly improved and glomerular filtration rates (GFR) were found to decline (from 130 +/- 18 to 116 +/- 15 ml/min/1.73 m2, P less than 0.01). The mean value of urinary albumin excretion (UAE) was not statistically significantly reduced (from 15.3 +/- 24.1 to 6.8 +/- 1.5 mg/24 h, P greater than 0.1). In the CIT group both GFR and UAE values were unchanged. In all subjects before treatment we found a positive correlation between the metabolic status, estimated by the HbA1c values, and GFR as well as UAE values, respectively (r = 0.64, P less than 0.01 and r = 0.42, P less than 0.05). We conclude that elevated GFR values can be reduced toward normal level by insulin pump treatment for 1 yr. Retinal morphology was found to deteriorate in four of 12 CIT subjects and in three of 12 CSII subjects. However, the progression was mild and in most individuals only due to a slight increase in the number of microaneurysms. Pump treatment did not induce proliferation and "cotton-wool" exudates were not detectable in any pump subject after 1 yr of treatment. We conclude that CSII treatment for 1 yr was unable to stop the progression of retinopathy in individuals with minimal or no retinopathy on entering the study. On the other hand, pump treatment did not induce cotton-wool exudates or proliferation in these subjects as previously reported in subjects with more severe retinopathy before CSII treatment.

Entities:  

Mesh:

Year:  1985        PMID: 4075944     DOI: 10.2337/diacare.8.6.585

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  Retinal function in relation to improved glycaemic control in type 1 diabetes.

Authors:  S K Holfort; K Nørgaard; G R Jackson; E Hommel; S Madsbad; I C Munch; K Klemp; B Sander; M Larsen
Journal:  Diabetologia       Date:  2011-04-26       Impact factor: 10.122

2.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

3.  Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells.

Authors:  W Li; X Liu; M Yanoff; S Cohen; X Ye
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

Review 4.  Diabetic control and microvascular complications: the near-normoglycaemic experience.

Authors:  K F Hanssen; K Dahl-Jørgensen; T Lauritzen; B Feldt-Rasmussen; O Brinchmann-Hansen; T Deckert
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

5.  Near-normoglycaemia and microvascular complications.

Authors:  I Mühlhauser; J Bruckner; K Howorka
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

Review 6.  Blood glucose control and microvascular complications--what do we do now?

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; H J Bangstad; K F Hanssen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

7.  Glomerular function and microalbuminuria in children with insulin-dependent diabetes.

Authors:  K Laborde; C Levy-Marchal; C Kindermans; M Dechaux; P Czernichow; C Sachs
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 8.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; L Sandvik; K F Hanssen
Journal:  BMJ       Date:  1992-01-04

Review 10.  Results of the DCCT trial. Implications for managing our patients with diabetes.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.